All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
Sonali Smith
Scientific Advisory Board Member
Professor Sonali Smith is the Elwood V. Jensen Professor in Medicine and Interim Chief of the Section of Hematology/Oncology, as well as the Director of the Adult Lymphoma Program at the University of Chicago, Chicago, US. She was educated at the Northwestern University Feinberg School of Medicine, Chicago, US, and completed her residency at Northwestern Memorial Hospital, Chicago, US, before her fellowship at the University of Chicago. She is an expert in the care and treatment of adults with all types of Hodgkin and non-Hodgkin lymphomas, and her clinical research interest lies in the development of new agents and combinations in the management of both treatment-naïve and relapsed/refractory lymphomas.
She is the Principal Investigator on a number of clinical trials and, through her role as Vice-Chair of the Southwest Oncology Group (SWOG) Lymphoma Committee, she is involved in clinical trial development at the cooperative group level across the US. She serves on many national committees aiming to improve treatment options for lymphoma, and through her research has co-authored nearly 180 publications. Besides this, she is involved in education of peers and patients, giving frequent presentations and lectures.
Positions of responsibility/awards:
- Vice-Chair of SWOG Lymphoma Committee
- Chair of the Career Development and Engagement Subcommittee for the American Society of Clinical Oncology (ASCO)
- Chairs the Women’s Networking Center for ASCO’s general meeting
- Member of the American Society of Hematology (ASH)
- Member of the National Cancer Institute’s Lymphoma Steering Committee
- Member of the Scientific Advisory Board for the Lymphoma Research Foundation
- Chair and organiser of the International John Ultmann Chicago Lymphoma Symposium
- Co-chair of the working group for lymphoma at the Center for International Bone and Marrow Transplant Research, 2015-18
- Deputy Editor of Hematology
- Editorial Board Member of Cancer and the Journal of Clinical Oncology
Filter by content: